News

Citurgia Biochemicals Limited informed the BSE Limited that the trading window for dealing in the company`s securities will be closed from October 01, 2026, and will remain closed until 48 hours after the declaration of the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended on September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Citurgia Biochemicals Limited has received approval from the Registrar of Companies, Mumbai, granting a one-month extension to convene its 51st Annual General Meeting (AGM) for the financial year ended March 31, 2026, allowing the company to hold the meeting on or before October 31, 2026. The extension was requested due to circumstances outlined in a letter attached to e-form SRN AC5761930 submitted on September 1, 2026, and follows prior board approval on August 31, 2026, to seek a three-month extension.

Citurgia Biochemicals will hold a meeting of the Board of Directors of the Company on 12 August 2026.

Net Loss of Citurgia Biochemicals reported to Rs 0.26 crore in the quarter ended March 2026 as against net loss of Rs 0.12 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net loss reported to Rs 0.74 crore in the year ended March 2026 as against net loss of Rs 0.42 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.Powered by Capital Market - Live News

Citurgia Biochemicals will hold a meeting of the Board of Directors of the Company on 30 May 2026.